当前位置：
X-MOL 学术
›
Eur. Urol.
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Long-term Outcomes and Patterns of Relapse Following High-dose Elective Salvage Radiotherapy and Hormone Therapy in Oligorecurrent Pelvic Nodes in Prostate Cancer: OLIGOPELVIS (GETUG-P07)
European Urology ( IF 23.4 ) Pub Date : 2024-03-14 , DOI: 10.1016/j.eururo.2024.02.013 Loig Vaugier , Cyrille Morvan , David Pasquier , Xavier Buthaud , Nicolas Magné , Veronique Beckendorf , Paul Sargos , Gilles Crehange , Pascal Pommier , Genevieve Loos , Ali Hasbini , Igor Latorzeff , Marlon Silva , Julie Paul , Audrey Blanc-Lapierre , Stéphane Supiot
European Urology ( IF 23.4 ) Pub Date : 2024-03-14 , DOI: 10.1016/j.eururo.2024.02.013 Loig Vaugier , Cyrille Morvan , David Pasquier , Xavier Buthaud , Nicolas Magné , Veronique Beckendorf , Paul Sargos , Gilles Crehange , Pascal Pommier , Genevieve Loos , Ali Hasbini , Igor Latorzeff , Marlon Silva , Julie Paul , Audrey Blanc-Lapierre , Stéphane Supiot
Pelvic radiotherapy offered prolonged tumor control for oligorecurrent prostate cancer in pelvic lymph nodes, and grade 2+ toxicity remained below 15%. Approximately one-third of patients were still in complete remission after 5 yr. Para-aortic lymph nodes were the main sites of relapse.
中文翻译：
前列腺癌少发盆腔淋巴结高剂量选择性挽救性放射治疗和激素治疗后的长期结果和复发模式：OLIGOPELVIS (GETUG-P07)
盆腔放疗为盆腔淋巴结少发性前列腺癌提供了长期的肿瘤控制，并且 2+ 级毒性保持在 15% 以下。大约三分之一的患者在 5 年后仍处于完全缓解状态。主动脉旁淋巴结是复发的主要部位。
更新日期：2024-03-14
中文翻译：
前列腺癌少发盆腔淋巴结高剂量选择性挽救性放射治疗和激素治疗后的长期结果和复发模式：OLIGOPELVIS (GETUG-P07)
盆腔放疗为盆腔淋巴结少发性前列腺癌提供了长期的肿瘤控制，并且 2+ 级毒性保持在 15% 以下。大约三分之一的患者在 5 年后仍处于完全缓解状态。主动脉旁淋巴结是复发的主要部位。
京公网安备 11010802027423号